Drug Shortage Report for SANDOZ MORPHINE SR
Report ID | 176026 |
Drug Identification Number | 02244791 |
Brand name | SANDOZ MORPHINE SR |
Common or Proper name | MORPHINE SR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100PRT |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2022-11-16 |
Estimated end date | 2023-02-03 |
Actual end date | 2023-02-08 |
Shortage status | Resolved |
Updated date | 2023-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-02-09 | French | Compare |
v6 | 2023-02-09 | English | Compare |
v5 | 2023-01-27 | French | Compare |
v4 | 2023-01-27 | English | Compare |
v3 | 2022-11-28 | French | Compare |
v2 | 2022-11-28 | English | Compare |
v1 | 2022-11-28 | English | Compare |
Showing 1 to 7 of 7